Allergic rhinoconjunctivitis

Michele Miraglia Del Giudice, Annalisa Allegorico, Gian Luigi Marseglia, Alberto Martelli, Mauro Calvani, Fabio Cardinale, Marzia Duse, Elena Chiappini, Sara Manti, Claudio Cravidi, Maria Angela Tosca, Carlo Caffarelli

Research output: Contribution to journalReview articlepeer-review


Allergic rhinitis (AR) is induced by an IgE-mediated immune reaction after allergen exposure. The typical symptoms are itching, nasal discharge, sneezing and nasal obstruction. The diagnosis is based on the concordance between allergic symptoms and diagnostic tests. The skin prick test (SPT) is recommended as the “gold standard” method. First generation H1-antihistamines are widely used for treatment of AR. Intranasal glucocorticosteroids are well tolerated and can be used also in paediatric age. Allergic rhinitis cannot be considered as an isolated pathology. Other atopic diseases (allergic conjunctivitis, atopic eczema, asthma) are commonly associated. (

Original languageEnglish
Article numbere2020007
Pages (from-to)1-3
Number of pages3
JournalActa Biomedica
Publication statusPublished - 2020


  • Allergen immunotherapy
  • Allergic rhinitis
  • Allergic rhinoconjunctivitis
  • H1-antihistamines
  • Intranasal corticosteroids
  • Local allergic rhinitis
  • Ocular allergy

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Allergic rhinoconjunctivitis'. Together they form a unique fingerprint.

Cite this